(Q40018113)

English

Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors.

scientific article published on February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Helen Su

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Yann Seimbille

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Claudia Bodenstein

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Barbara Fueger

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Kevin J Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Yu-Tien Hsu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Steven M Dubinett

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Michael E Phelps

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Johannes Czernin

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Wolfgang A Weber

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

number of pages

11

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1089-1099

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239919%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

https://scigraph.springernature.com/pub.10.1007/s00259-007-0636-6

0 references

The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting the epidermal growth factor receptor. Trials in head and neck and lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Where next for gefitinib in patients with lung cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular targets of gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AMIDE: a free software tool for multimodality medical image analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular imaging of EGFR kinase activity in tumors with 124I-labeled small molecular tracer and positron emission tomography.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical experience with gefitinib: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An internet-based "kinetic imaging system" (KIS) for MicroPET.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting the epidermal growth factor receptor for cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotracers for positron emission tomography imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-dose clinical pharmacokinetic studies of gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis of [11C]Iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumor xenografts using radiolabeled EGF and anti-(EGF receptor) mAb 425

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18239919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40018113&oldid=1806990124"